APA
25
-3
WU
12
-4
C
60
-2
ALLE
57
-7
SWN
77
4
MCD
67
2
HAS
55
-2
SCHW
52
3
HSIC
50
-3
PSA
66
3
CFG
38
-2
MS
64
7
SWKS
38
-2
MSI
72
2
SHW
71
-2
VRSK
35
-3
WFC
63
3
CCL
68
-4
ILMN
41
-3
JBHT
50
-6
APA
25
-3
WU
12
-4
C
60
-2
ALLE
57
-7
SWN
77
4
MCD
67
2
HAS
55
-2
SCHW
52
3
HSIC
50
-3
PSA
66
3
CFG
38
-2
MS
64
7
SWKS
38
-2
MSI
72
2
SHW
71
-2
VRSK
35
-3
WFC
63
3
CCL
68
-4
ILMN
41
-3
JBHT
50
-6
Financhill
Back

iShares Global Monthly Div ETF CADH Comm Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
64

CYH.TO
iShares Global Monthly Div ETF CADH Comm

Last Price:
21.93
Seasonality Move:
-0.68%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Buy
64
iShares Global Monthly Div ETF CADH Comm (CYH.TO) is a Buy

Is iShares Global Monthly Div ETF CADH Comm a Buy, Sell or Hold?

  • The current iShares Global Monthly Div ETF CADH Comm [CYH.TO] share price is $21.93. The Score for CYH.TO is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • CYH.TO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

CYH.TO Stock Price Chart

What is iShares Global Monthly Div ETF CADH Comm's stock price today?

  • The iShares Global Monthly Div ETF CADH Comm share price today is $21.93
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CYH.TO is experiencing slight buying pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

CYH.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.16 Buy
Relative Strength Index (14 RSI): 60.17 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.46 - 21.86) Buy
Bollinger Bands (100): (20.55 - 21.51) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

CYH.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.79 Buy
20-day SMA: 21.72 Buy
50-day SMA: 21.39 Buy
200-day SMA: 20.44 Buy
8-day EMA: 21.84 Buy
20-day EMA: 21.69 Buy
50-day EMA: 21.4 Buy
200-day EMA: 20.57 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

iShares Global Monthly Div ETF CADH Comm Earnings Growth & CYH.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

iShares Global Monthly Div ETF CADH Comm Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):